Racioppi, Marco
 Distribuzione geografica
Continente #
EU - Europa 18.689
NA - Nord America 5.600
AS - Asia 3.936
SA - Sud America 817
AF - Africa 126
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 29.198
Nazione #
IT - Italia 12.858
US - Stati Uniti d'America 5.422
DE - Germania 1.862
SG - Singapore 1.828
CN - Cina 1.056
SE - Svezia 901
NL - Olanda 747
BR - Brasile 670
FR - Francia 590
UA - Ucraina 478
GB - Regno Unito 326
IN - India 260
IE - Irlanda 214
VN - Vietnam 152
ID - Indonesia 144
PL - Polonia 128
FI - Finlandia 122
RU - Federazione Russa 121
CA - Canada 102
CH - Svizzera 81
JP - Giappone 81
HK - Hong Kong 69
TR - Turchia 62
AR - Argentina 57
ES - Italia 54
BE - Belgio 51
BD - Bangladesh 50
MX - Messico 43
IQ - Iraq 36
ZA - Sudafrica 31
KR - Corea 28
AT - Austria 24
CI - Costa d'Avorio 24
EC - Ecuador 22
MA - Marocco 22
PK - Pakistan 21
CO - Colombia 19
RO - Romania 19
IR - Iran 18
AE - Emirati Arabi Uniti 16
AL - Albania 16
AZ - Azerbaigian 15
VE - Venezuela 13
AU - Australia 12
IL - Israele 12
CL - Cile 11
EG - Egitto 11
GR - Grecia 11
LT - Lituania 11
PE - Perù 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
JO - Giordania 8
TN - Tunisia 8
TW - Taiwan 8
PT - Portogallo 7
TT - Trinidad e Tobago 7
EU - Europa 6
HU - Ungheria 6
KG - Kirghizistan 6
LK - Sri Lanka 6
MY - Malesia 6
NP - Nepal 6
RS - Serbia 6
TH - Thailandia 6
BO - Bolivia 5
CR - Costa Rica 5
DZ - Algeria 5
IS - Islanda 5
KE - Kenya 5
NZ - Nuova Zelanda 5
PA - Panama 5
PH - Filippine 5
SM - San Marino 5
UY - Uruguay 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
HN - Honduras 4
HR - Croazia 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BY - Bielorussia 3
CV - Capo Verde 3
ET - Etiopia 3
KW - Kuwait 3
LU - Lussemburgo 3
NG - Nigeria 3
PY - Paraguay 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BZ - Belize 2
CG - Congo 2
DK - Danimarca 2
EE - Estonia 2
JM - Giamaica 2
MD - Moldavia 2
MT - Malta 2
Totale 29.165
Città #
Milan 1.276
Rome 1.126
Chandler 988
Singapore 817
Ashburn 589
Naples 376
Jacksonville 263
Florence 238
Turin 234
Beijing 212
Dublin 206
San Mateo 205
Los Angeles 194
Bologna 180
Ann Arbor 169
Palermo 155
Bari 148
Nanjing 147
Wilmington 140
Jakarta 134
New York 123
Catania 113
Genoa 110
Munich 103
Verona 100
Hefei 96
Dearborn 90
Bremen 85
Nürnberg 85
Kraków 82
São Paulo 81
Boston 77
Nanchang 75
Woodbridge 75
Frankfurt am Main 72
Lawrence 71
Moscow 68
Brescia 67
Hong Kong 66
Redwood City 63
Marseille 62
Houston 61
Padova 58
Ho Chi Minh City 54
The Dalles 52
Cagliari 49
Venice 49
Seattle 48
Parma 46
Taranto 46
Dallas 45
Hanoi 43
Hyderabad 42
Bergamo 41
Perugia 41
Lancaster 39
Ottawa 39
Princeton 39
Brussels 38
Buffalo 38
Messina 38
Pescara 37
Reggio Emilia 37
Mountain View 36
Salerno 36
Cattolica 34
Fairfield 32
Livorno 32
Chicago 31
Santa Clara 30
Redmond 29
Kadoma 28
London 28
Lucca 28
Stockholm 28
Falls Church 27
Modena 27
Tianjin 27
Tokyo 27
Trieste 27
Kent 26
Kunming 26
Monza 26
Helsinki 25
Abidjan 24
Atlanta 24
Novara 24
Seoul 24
Toronto 24
Rimini 23
Augusta 22
Izmir 22
Belo Horizonte 21
Hebei 21
Jiaxing 20
Johannesburg 20
Paris 20
Shenyang 20
University Park 20
Boardman 19
Totale 11.499
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.158
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.183
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 904
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 558
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 399
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 330
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 305
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 299
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 296
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 229
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 215
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 205
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 201
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 181
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 176
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 171
The occult urothelial cancer 170
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 167
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 166
Male infertility: non-surgical therapy 164
Haemodynamic changes detected during open prostatectomy and transurethral resection for benign prostatic hyperplasia 161
Hot topics in urological health economics. A mini review 154
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 154
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 152
[Overactive bladder syndrome: the social and economic perspective] 148
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 148
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 148
Imaging in prostate cancer diagnosis: present role and future perspectives 147
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 147
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 146
Bladder and prostate metastasis from small cell lung cancer: a rare entity 146
Antibiotic prophylaxis in urology 145
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 142
Advanced bladder cancer: New agents and new approaches. A review 141
Imaging in prostate cancer staging: present role e future perspectives 140
Imaging of renal cell carcinoma: state of the art and recent advances 138
Acid-base and electrolyte balance in urinary intestinal orthotopic reservoir: ileocecal neobladder compared with ileal neobladder 137
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 137
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 136
Advanced bladder cancer: New agents and new approaches. A review 135
Size of Bladder Cancers: Correlation among Different Types of Measurement 135
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 135
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 133
Therapeutic strategies in penile cancer: state of the art 133
NBI: results review 133
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 131
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 129
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 128
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 126
Imaging in prostate cancer staging: present role and future perspectives 126
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 125
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 123
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 122
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 122
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 122
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 122
Long-term behaviour of secretory immunity in ileocecal and ileal orthotopic neobladders. 121
Circumcision: history, religion and law 121
[Innovative treatments of non muscle invasive bladder cancer] 121
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 121
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 120
Mitomycin C: new strategies to improve efficacy of a well-known therapy 118
The occult urothelial cancer 117
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 116
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 115
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 114
Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study 112
Imaging of renal cell carcinoma: state of the art and recent advances 112
Therapy for non-muscle invasive bladder cancer: HP-NAP 112
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 112
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 111
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 111
Second-line intravesical therapy. What is the present role of device-assisted therapy? 111
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 108
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 107
Vitamin B12 and folic acid plasma levels after ileocecal and ileal neobladder reconstruction 107
Imaging in prostate cancer diagnosis: present role and future perspectives 107
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 106
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 105
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 104
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 102
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 98
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 95
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 94
Imaging of renal cell carcinoma: state of the art and recent advances. 93
Quality of life following urinary diversion: Orthotopic ileal neobladder versus ileal conduit. A multicentre study among long-term, female bladder cancer survivors 92
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 91
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 89
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 89
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 89
[Doping and urologic tumors] 87
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 86
Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta-analysis 86
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 85
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 85
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens 83
Sports and Genitourinary Traumas 83
Simultaneous surgical management of renal cancer with atrial thrombotic extension and severe chronic coronary artery disease: a case report 82
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer 82
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 80
Totale 26.904
Categoria #
all - tutte 79.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021704 0 0 0 0 0 69 134 43 146 66 181 65
2021/20221.385 136 86 45 104 110 77 56 174 94 81 189 233
2022/20234.082 416 397 268 493 215 396 196 338 441 213 400 309
2023/20245.933 330 583 373 514 407 456 453 575 426 565 559 692
2024/20258.328 580 690 746 629 798 608 619 647 946 653 797 615
2025/20264.282 1.204 375 513 801 1.286 103 0 0 0 0 0 0
Totale 29.353